Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 1
2018 1
2020 1
2021 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Enhancing venetoclax activity in hematological malignancies.
Satta T, Grant S. Satta T, et al. Expert Opin Investig Drugs. 2020 Jul;29(7):697-708. doi: 10.1080/13543784.2020.1789588. Epub 2020 Jul 16. Expert Opin Investig Drugs. 2020. PMID: 32600066 Free PMC article. Review.
Clinical experience of CAR T cells for multiple myeloma.
Simmons GL, Satta T, Castaneda Puglianini O. Simmons GL, et al. Among authors: satta t. Best Pract Res Clin Haematol. 2021 Sep;34(3):101306. doi: 10.1016/j.beha.2021.101306. Epub 2021 Aug 28. Best Pract Res Clin Haematol. 2021. PMID: 34625232 Review.
Blood Transfusion Management and Transfusion-Related Outcomes in Daratumumab-Treated Patients With Relapsed or Refractory Multiple Myeloma.
Chari A, Arinsburg S, Jagannath S, Satta T, Treadwell I, Catamero D, Morgan G, Feng H, Uhlar C, Khan I, Doshi P, Usmani S. Chari A, et al. Among authors: satta t. Clin Lymphoma Myeloma Leuk. 2018 Jan;18(1):44-51. doi: 10.1016/j.clml.2017.09.002. Epub 2017 Sep 19. Clin Lymphoma Myeloma Leuk. 2018. PMID: 29054515 Free article.
Frontline therapy with high-dose imatinib versus second generation tyrosine kinase inhibitor in patients with chronic-phase chronic myeloid leukemia - a propensity score analysis.
Sasaki K, Kantarjian H, Jabbour E, Ravandi F, Takahashi K, Konopleva M, Borthakur G, Garcia-Manero G, Wierda W, Daver N, Jain P, Satta T, Pierce S, Rios MB, Cortes JE. Sasaki K, et al. Among authors: satta t. Haematologica. 2016 Aug;101(8):e324-7. doi: 10.3324/haematol.2015.139089. Epub 2016 May 12. Haematologica. 2016. PMID: 27175025 Free PMC article. No abstract available.